Alain Scaiola
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Structural Biology top 10%
Papers in
-
- RNA and protein synthesis mechanisms 9
- RNA modifications and cancer 6
- Genomics and Phylogenetic Studies 2
- Protein Kinase Regulation and GTPase Signaling 2
- Oncology 6
- Peptidase Inhibition and Analysis 4
- PARP inhibition in cancer therapy 2
- Co-authors
- Nenad Ban (17 shared papers)Marc Leibundgut (9 shared papers)Volker Thiel (3 shared papers)Katharina Schubert (4 shared papers)Evangelos D. Karousis (3 shared papers)Oliver Mühlemann (3 shared papers)Lukas‐Adrian Gurzeler (2 shared papers)Ahmad Jomaa (2 shared papers)
- Journals
- Science (5 papers)Molecular Cell (3 papers)Nature Structural & Molecular Biology (2 papers)Science Advances (2 papers)The EMBO Journal (1 paper)
- Partner nations
- SwitzerlandUnited StatesRussia
In The Last Decade
Alain Scaiola
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Infectious Diseases 380
- Structural Biology 17
- Molecular Biology 729
- Animal Science and Zoology 63
- Immunology 127
Countries citing papers authored by Alain Scaiola
This map shows the geographic impact of Alain Scaiola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Scaiola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Scaiola more than expected).
Fields of papers citing papers by Alain Scaiola
This network shows the impact of papers produced by Alain Scaiola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Scaiola. The network helps show where Alain Scaiola may publish in the future.
Co-authors
The 25 scholars most cited alongside Alain Scaiola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation Hit paper breakdown → | 2020 | 383 |
| 2 | Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome Hit paper breakdown → | 2021 | 176 |
| 3 | 2018 | 72 | |
| 4 | 2020 | 67 | |
| 5 | 2018 | 61 | |
| 6 | 2022 | 56 | |
| 7 | 2019 | 52 | |
| 8 | 2021 | 38 | |
| 9 | 2021 | 33 | |
| 10 | 2023 | 24 | |
| 11 | 2023 | 24 | |
| 12 | 2023 | 20 | |
| 13 | 2019 | 19 | |
| 14 | 2020 | 15 | |
| 15 | 2024 | 14 | |
| 16 | 2025 | 2 | |
| 17 | 2019 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2022 | 0 |
About Alain Scaiola
Alain Scaiola is a scholar working on Molecular Biology, Oncology, Cell Biology, Genetics and Infectious Diseases, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (9 papers), RNA modifications and cancer (6 papers), Peptidase Inhibition and Analysis (4 papers), Bacterial Genetics and Biotechnology (2 papers), Genomics and Phylogenetic Studies (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), PARP inhibition in cancer therapy (2 papers) and Enzyme Structure and Function (2 papers). The work is most often cited by research in Infectious Diseases (380 citations), Structural Biology (17 citations), Molecular Biology (729 citations), Animal Science and Zoology (63 citations) and Immunology (127 citations). Alain Scaiola has collaborated with scholars based in Switzerland, United States and Russia. Frequent co-authors include Nenad Ban, Marc Leibundgut, Volker Thiel, Katharina Schubert, Evangelos D. Karousis, Oliver Mühlemann, Lukas‐Adrian Gurzeler, Ahmad Jomaa, Daniel Boehringer and René Dreos. Their work appears in journals such as Science, Molecular Cell, Nature Structural & Molecular Biology, Science Advances and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.